Monday, June 13, 2016

BRIEF-Marinus Pharmaceuticals says Ganaxolone did not meet primary endpoint

* Marinus plans to discontinue its program in adult focal

onset seizures

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)